[{"address1": "4475 Executive Drive", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 794 9600", "fax": "858 794 9605", "website": "https://www.calidibio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allan J. Camaisa", "age": 63, "title": "CEO & Chairman of the Board", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 306180, "exercisedValue": 0, "unexercisedValue": 1894234}, {"maxAge": 1, "name": "Ms. Wendy  Pizarro Campbell Esq.", "age": 52, "title": "Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 295404, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Boris  Minev M.D., Ph.D.", "age": 60, "title": "President of Medical & Scientific Affairs and Interim Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 400096, "exercisedValue": 0, "unexercisedValue": 132432}, {"maxAge": 1, "name": "Mr. Andrew C. Jackson", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Thesing", "age": 57, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.01, "open": 2.02, "dayLow": 1.9401, "dayHigh": 2.16, "regularMarketPreviousClose": 2.01, "regularMarketOpen": 2.02, "regularMarketDayLow": 1.9401, "regularMarketDayHigh": 2.16, "beta": 0.575, "forwardPE": -2.3333333, "volume": 1156133, "regularMarketVolume": 1156133, "averageVolume": 1398134, "averageVolume10days": 1201360, "averageDailyVolume10Day": 1201360, "bid": 2.11, "ask": 2.13, "bidSize": 1800, "askSize": 1000, "marketCap": 36783388, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 24.0, "fiftyDayAverage": 1.54286, "twoHundredDayAverage": 2.52895, "currency": "USD", "enterpriseValue": 24955562, "floatShares": 5354862, "sharesOutstanding": 17515900, "sharesShort": 585626, "sharesShortPriorMonth": 161034, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.050100002, "heldPercentInsiders": 0.18159, "heldPercentInstitutions": 0.02707, "shortRatio": 0.88, "shortPercentOfFloat": 0.0577, "impliedSharesOutstanding": 17515900, "bookValue": -2.318, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -24916000, "trailingEps": -1.04, "forwardEps": -0.9, "lastSplitFactor": "1:10", "lastSplitDate": 1721001600, "enterpriseToEbitda": -0.855, "52WeekChange": -0.9045454, "SandP52WeekChange": 0.31754446, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "CLDI", "underlyingSymbol": "CLDI", "shortName": "Calidi Biotherapeutics, Inc.", "longName": "Calidi Biotherapeutics, Inc.", "firstTradeDateEpochUtc": 1635773400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "9a7984e0-6061-3b4d-bf45-163ad44f97ec", "messageBoardId": "finmb_572193913", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.1, "targetHighPrice": 10.0, "targetLowPrice": 2.5, "targetMeanPrice": 6.25, "targetMedianPrice": 6.25, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 836000, "totalCashPerShare": 0.103, "ebitda": -29177000, "totalDebt": 8734000, "quickRatio": 0.078, "currentRatio": 0.125, "returnOnAssets": -2.22494, "freeCashflow": -47570124, "operatingCashflow": -28028000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]